# Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients

> **NCT01291459** · PHASE2 · UNKNOWN · sponsor: **Association Pour la Recherche en Infectiologie** · enrollment: 40 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir

## Key facts

- **NCT ID:** NCT01291459
- **Lead sponsor:** Association Pour la Recherche en Infectiologie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291459, "Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01291459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*